Donepezil delay to nursing home placement study is flawed.
Karlawish
Jason H T
JH
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000401:mortality; D017028:Caregivers; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D000077265:Donepezil; D006801:Humans; D007189:Indans / Q000008:administration & dosage / Q000627:therapeutic use*; D007326:Institutionalization; D018697:Nootropic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D009735:Nursing Homes; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012106:Research; D013997:Time Factors; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D000077265:Donepezil